Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

327 total articles

AAOI: Momentum Breakout — Position for the Next Leg Higher

AAOI: Momentum Breakout — Position for the Next Leg Higher

Applied Optoelectronics has rallied from pandemic-era lows into a technically clean uptrend driven by accelerating hyperscale/data-center orders and product wins. The chart breakout is supported by improving fundamentals and heavy short interest that can fuel a squeeze. This trade idea outlines an actionable long with entry, stop and target, plus c…

Pfizer at a Crossroads: High-Yield Income Trade with Mid-Term Upside

Pfizer at a Crossroads: High-Yield Income Trade with Mid-Term Upside

Pfizer offers a generous ~6.7% yield, a below-average valuation (PE ~15, EV/EBITDA ~8.8) and free cash flow roughly $10.4B — characteristics attractive for income-seeking investors. The company also has potential upside from early oncology and weight-management launches. This trade idea lays out a mid-term long plan (45 trading days) with entry, st…

AMN Is Cheap Relative to Cash Flow; a Mid-Trade Long for a Recovery Play

AMN Is Cheap Relative to Cash Flow; a Mid-Trade Long for a Recovery Play

AMN Healthcare Services (AMN) looks attractively priced on free cash flow and EV/EBITDA despite negative earnings and elevated leverage. Management expects a recovery in travel and allied staffing demand; combine that with a Technology & Workforce push and a still-low P/S and the stock offers an asymmetric reward-to-risk profile for a mid-term trad…

Pinterest: Buy the Attribution Singularity at a Cheap Multiple

Pinterest: Buy the Attribution Singularity at a Cheap Multiple

Pinterest is cheap on traditional metrics, trading near $23 with a sub-8x P/E, strong free cash flow and zero debt. Management's pivot to AI and connected-TV advertising (post-tvScientific) creates a clear monetization runway. Enter a long, defined-risk trade targeting a return to mid‑cycle multiples while watching execution risks tied to restructu…

Playing the Merger Run: Long CCIX Ahead of an AI Trucking SPAC Move

Playing the Merger Run: Long CCIX Ahead of an AI Trucking SPAC Move

Churchill Capital Corp IX (CCIX) is a blank-check vehicle trading at $10.67 with a market cap of roughly $391M. This trade idea takes a tactical long into expected merger-related momentum around an AI trucking target: entry at $10.67, stop at $10.15, target $12.50, mid-term horizon (45 trading days). The setup mixes tight technicals, low float rela…

Chubb: Buy the Quiet Stability or Wait for a Bigger Re-rate?

Chubb: Buy the Quiet Stability or Wait for a Bigger Re-rate?

Chubb trades like a high-quality insurer at a reasonable price: double-digit ROE, P/E near 12, and a 52-week range that still leaves room above current levels. I lay out a mid-term (45 trading days) swing trade to capture an 8% move toward $328 while limiting downside with a $292 stop. The thesis balances stable underwriting performance and balance…

UnitedHealth: Buy the Market Leader After a Policy-Driven Washout

UnitedHealth: Buy the Market Leader After a Policy-Driven Washout

UnitedHealth (UNH) is a structurally advantaged insurer and healthcare services platform that just got cheaper after a policy surprise and disappointing top-line guidance. Fundamentals still show strong free cash flow, a reasonable valuation and operating leverage through Optum. This trade buys the dip with a defined stop and a 180 trading-day targ…

Meta’s Next Leg Up: Why $900 Is a Realistic 2026 Target

Meta’s Next Leg Up: Why $900 Is a Realistic 2026 Target

Meta surged after Q4 strength and looks set to extend gains as AI tailwinds roll through its ad and infrastructure businesses. Valuation is reasonable given free cash flow strength and low leverage. This trade plan targets $900 over the next 180 trading days with a strict stop at $640 to respect the technical picture and protect against macro-drive…

Why Sportradar (SRAD) Is One of My Highest-Conviction Longs for 2026

Why Sportradar (SRAD) Is One of My Highest-Conviction Longs for 2026

Sportradar is a market leader in sports data and betting technology with accelerating margins, a string of strategic deals (IMG ARENA, Bundesliga expansion), active buybacks and a current technical oversold setup. At a market cap of ~$5.8B and rich but justifiable growth expectations, I view SRAD as a long-term trade for investors willing to tolera…